BOK Financial’s BeOne Medicines Ltd ONC Stock Holding History

BOK Financial’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14	Closed	-$3.02K	–	1191
2023 Q1	$3.02K	Buy	+14	New	+$3.36K	﹤0.01%	1096

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

BOK Financial's ONC Position: Q2 2023 in Review

BOK Financial sold out of BeOne Medicines Ltd (ONC) in Q2 2023, closing a stake of 14 shares — an estimated $3.02K sold.

BOK Financial first reported a position in ONC in Q1 2023 and held it in 1 quarter. The position peaked at $3.02K in Q1 2023. 208 funds tracked by Wall St. Rank hold ONC as of Q2 2023.

BOK Financial reported no remaining BeOne Medicines Ltd position as of Q2 2023 after selling out during the quarter.
BOK Financial sold 14 BeOne Medicines Ltd shares in Q2 2023, an estimated $3.02K.
BOK Financial first reported a position in BeOne Medicines Ltd in Q1 2023 and held it in 1 quarter.
BOK Financial's BeOne Medicines Ltd position peaked at $3.02K in Q1 2023.
208 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2023.

Based on BOK Financial's 13F filing for Q2 2023, filed 21 Aug 2023.